Summary of the National Advisory Committee on Immunization (NACI) Statement on the Prevention of Respiratory Syncytial Virus (RSV) in Infants
Based on new evidence, NACI recommends building towards a universal RSV immunization program for all infants. Currently, nirsevimab is preferred over RSVpreF. Program introduction could occur in stages depending on access to supply, cost effectiveness, and affordability of available options.
Authors
- Winnie Siu (ORCID: https://orcid.org/0009-0001-5772-1509)
- April Killikelly
- Nicholas Brousseau (ORCID: https://orcid.org/0000-0001-6042-3177)
Institutions
- University of Ottawa (CA)
- Public Health Agency of Canada (CA)
Publication Details
- Journal
- Canada Communicable Disease Report
- Published
- 2025-04-03
- DOI
- https://doi.org/10.14745/ccdr.v51i04a01
- Citations
- 7
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 9.48